Now live: Pro — the full 13F research suite for serious investorsSee pricing →
DME Capital Management, LP

Q1 2024 · 13F-HR

DME Capital Management, LPholdings as filed

Filed 2024-05-15 · accession 0001172661-24-002489

$2.18B
Reported value
42
Positions
2024-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
392709101GRBKGREEN BRICK PARTNERS INC$630.5M28.9%10,467,383CommonSOLE
10922N103BHFBRIGHTHOUSE FINL INC$155.7M7.13%3,021,763CommonSOLE
50155Q100KDKYNDRYL HLDGS INC$143.7M6.58%6,605,059CommonSOLE
20854L108CEIXEURCONSOL ENERGY INC NEW$137.4M6.29%1,640,750CommonSOLE
01626W101ALITALIGHT INC$113.6M5.20%11,527,930CommonSOLE
88033G407THCTENET HEALTHCARE CORP$93.6M4.28%890,630CommonSOLE
88337F105ODP1THE ODP CORP$90.7M4.15%1,710,580CommonSOLE
707569109PENNPENN ENTERTAINMENT INC$82.9M3.80%4,554,710CommonSOLE
G5509L101LIVNLIVANOVA PLC$74.6M3.41%1,332,804CommonSOLE
878742204TECKTECK RESOURCES LTD$71.1M3.25%1,552,063CommonSOLE
92556V106VTRSVIATRIS INC$53.9M2.47%4,517,620CommonSOLE
388689101GPKGRAPHIC PACKAGING HLDG CO$52.4M2.40%1,796,130CommonSOLE
78463V107GLDSPDR GOLD TR$50.7M2.32%246,671CommonSOLE
40434L105HPQHP INC$48.8M2.24%1,615,960CommonSOLE
Y2065G121DHTDHT HOLDINGS INC$46.3M2.12%4,024,340CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$44.2M2.02%4,190,490CommonSOLE
31946M103FCNCAFIRST CTZNS BANCSHARES INC N$41.1M1.88%25,160CommonSOLE
G48833118WFRDWEATHERFORD INTL PLC$36.6M1.68%317,477CommonSOLE
G61188101LBTYALIBERTY GLOBAL LTD$34.5M1.58%2,041,580CommonSOLE
G7997W102SDRLSEADRILL 2021 LTD$28.6M1.31%569,405CommonSOLE
N00985106AERAERCAP HOLDINGS NV$27.7M1.27%319,050CommonSOLE
64107A105NPWRNET POWER INC$22.3M1.02%1,959,280CommonSOLE
46137V100PPAINVESCO EXCHANGE TRADED FD T$18.5M0.85%182,511CommonSOLE
78464A631XARSPDR SER TR$17.9M0.82%127,557CommonSOLE
49177J102KVUEKENVUE INC$15.2M0.70%707,740CommonSOLE
22407B108COYACOYA THERAPEUTICS INC$12.6M0.58%1,274,026CommonSOLE
38268T103GPROGOPRO INC$6.3M0.29%2,823,100CommonSOLE
36315X101LKFTGALAPAGOS NV$5.1M0.24%159,828CommonSOLE
881624209TEVATEVA PHARMACEUTICAL INDS LTD$4.6M0.21%324,850CommonSOLE
92189H607OIHVANECK ETF TRUST$3.8M0.17%11,220CommonSOLE
83601L102SHCSOTERA HEALTH CO$3.6M0.16%300,110CommonSOLE
92189F106GDXVANECK ETF TRUST$3.5M0.16%111,390CommonSOLE
236272100DANIMER SCIENTIFIC INC$3.0M0.14%2,734,580CommonSOLE
36269B105GANXGAIN THERAPEUTICS INC$2.1M0.10%566,130CommonSOLE
G21810109CLVTCLARIVATE PLC$2.1M0.10%279,560CommonSOLE
33733E807FCGFIRST TR EXCHANGE-TRADED FD$1.9M0.09%70,830CommonSOLE
46090F100PDBCINVESCO ACTVELY MNGD ETC FD$1.6M0.07%117,360CommonSOLE
87424L207TLISTALIS BIOMEDICAL CORP$1.3M0.06%149,052CommonSOLE
67080N101NUVBNUVATION BIO INC$127,3820.01%34,995CommonSOLE
64132K201OHRPEURNEUBASE THERAPEUTICS INC$61,3440.00%136,350CommonSOLE
67080N119NUVB/WSNUVATION BIO INC$30,2500.00%100,000CommonSOLE
485859110KPLTWKATAPULT HOLDINGS INC$5,1920.00%262,227CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.